199 related articles for article (PubMed ID: 23525378)
1. Amygdalin inhibits renal fibrosis in chronic kidney disease.
Guo J; Wu W; Sheng M; Yang S; Tan J
Mol Med Rep; 2013 May; 7(5):1453-7. PubMed ID: 23525378
[TBL] [Abstract][Full Text] [Related]
2. Delayed administration of hepatocyte growth factor reduces renal fibrosis in obstructive nephropathy.
Yang J; Liu Y
Am J Physiol Renal Physiol; 2003 Feb; 284(2):F349-57. PubMed ID: 12529273
[TBL] [Abstract][Full Text] [Related]
3. A novel STAT3 inhibitor, S3I-201, attenuates renal interstitial fibroblast activation and interstitial fibrosis in obstructive nephropathy.
Pang M; Ma L; Gong R; Tolbert E; Mao H; Ponnusamy M; Chin YE; Yan H; Dworkin LD; Zhuang S
Kidney Int; 2010 Aug; 78(3):257-68. PubMed ID: 20520592
[TBL] [Abstract][Full Text] [Related]
4. Diverse roles of TGF-β receptor II in renal fibrosis and inflammation in vivo and in vitro.
Meng XM; Huang XR; Xiao J; Chen HY; Zhong X; Chung AC; Lan HY
J Pathol; 2012 Jun; 227(2):175-88. PubMed ID: 22190171
[TBL] [Abstract][Full Text] [Related]
5. Chronic unilateral ureteral obstruction is associated with interstitial fibrosis and tubular expression of transforming growth factor-beta.
Wright EJ; McCaffrey TA; Robertson AP; Vaughan ED; Felsen D
Lab Invest; 1996 Feb; 74(2):528-37. PubMed ID: 8780170
[TBL] [Abstract][Full Text] [Related]
6. Nintedanib, a triple tyrosine kinase inhibitor, attenuates renal fibrosis in chronic kidney disease.
Liu F; Wang L; Qi H; Wang J; Wang Y; Jiang W; Xu L; Liu N; Zhuang S
Clin Sci (Lond); 2017 Aug; 131(16):2125-2143. PubMed ID: 28646122
[TBL] [Abstract][Full Text] [Related]
7. Vitamin E ameliorates renal fibrosis by inhibition of TGF-beta/Smad2/3 signaling pathway in UUO mice.
Tasanarong A; Kongkham S; Duangchana S; Thitiarchakul S; Eiam-Ong S
J Med Assoc Thai; 2011 Dec; 94 Suppl 7():S1-9. PubMed ID: 22619900
[TBL] [Abstract][Full Text] [Related]
8. LSKL, a peptide antagonist of thrombospondin-1, attenuates renal interstitial fibrosis in rats with unilateral ureteral obstruction.
Xie XS; Li FY; Liu HC; Deng Y; Li Z; Fan JM
Arch Pharm Res; 2010 Feb; 33(2):275-84. PubMed ID: 20195829
[TBL] [Abstract][Full Text] [Related]
9. Vitamin E ameliorates renal fibrosis in ureteral obstruction: role of maintaining BMP-7 during epithelial-to-mesenchymal transition.
Tasanarong A; Kongkham S; Thitiarchakul S; Eiam-Ong S
J Med Assoc Thai; 2011 Dec; 94 Suppl 7():S10-8. PubMed ID: 22619901
[TBL] [Abstract][Full Text] [Related]
10. Preventive effects and mechanisms of rhein on renal interstitial fibrosis in obstructive nephropathy.
He D; Lee L; Yang J; Wang X
Biol Pharm Bull; 2011; 34(8):1219-26. PubMed ID: 21804209
[TBL] [Abstract][Full Text] [Related]
11. 3-Bromopyruvate decreased kidney fibrosis and fibroblast activation by suppressing aerobic glycolysis in unilateral ureteral obstruction mice model.
Yu H; Zhu J; Chang L; Liang C; Li X; Wang W
Life Sci; 2021 May; 272():119206. PubMed ID: 33577854
[TBL] [Abstract][Full Text] [Related]
12. Renal damage progresses despite improvement of renal function after relief of unilateral ureteral obstruction in adult rats.
Ito K; Chen J; El Chaar M; Stern JM; Seshan SV; Khodadadian JJ; Richardson I; Hyman MJ; Vaughan ED; Poppas DP; Felsen D
Am J Physiol Renal Physiol; 2004 Dec; 287(6):F1283-93. PubMed ID: 15328069
[TBL] [Abstract][Full Text] [Related]
13. Poricoic acid A activates AMPK to attenuate fibroblast activation and abnormal extracellular matrix remodelling in renal fibrosis.
Chen DQ; Wang YN; Vaziri ND; Chen L; Hu HH; Zhao YY
Phytomedicine; 2020 Jul; 72():153232. PubMed ID: 32460034
[TBL] [Abstract][Full Text] [Related]
14. Sustained-release prostacyclin analog ONO-1301 ameliorates tubulointerstitial alterations in a mouse obstructive nephropathy model.
Nasu T; Kinomura M; Tanabe K; Yamasaki H; Htay SL; Saito D; Hinamoto N; Watatani H; Ujike H; Suzuki Y; Sugaya T; Sugiyama H; Sakai Y; Matsumoto K; Maeshima Y; Makino H
Am J Physiol Renal Physiol; 2012 Jun; 302(12):F1616-29. PubMed ID: 22419696
[TBL] [Abstract][Full Text] [Related]
15. Inhibiting aerobic glycolysis suppresses renal interstitial fibroblast activation and renal fibrosis.
Ding H; Jiang L; Xu J; Bai F; Zhou Y; Yuan Q; Luo J; Zen K; Yang J
Am J Physiol Renal Physiol; 2017 Sep; 313(3):F561-F575. PubMed ID: 28228400
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of class I HDACs attenuates renal interstitial fibrosis in a murine model.
Yang M; Chen G; Zhang X; Guo Y; Yu Y; Tian L; Chang S; Chen ZK
Pharmacol Res; 2019 Apr; 142():192-204. PubMed ID: 30807866
[TBL] [Abstract][Full Text] [Related]
17. The antifibrotic effect of a serine protease inhibitor in the kidney.
Morinaga J; Kakizoe Y; Miyoshi T; Onoue T; Ueda M; Mizumoto T; Yamazoe R; Uchimura K; Hayata M; Shiraishi N; Adachi M; Sakai Y; Tomita K; Kitamura K
Am J Physiol Renal Physiol; 2013 Jul; 305(2):F173-81. PubMed ID: 23698112
[TBL] [Abstract][Full Text] [Related]
18. Dihydroartemisinin attenuates renal fibrosis through regulation of fibroblast proliferation and differentiation.
Zhang B; Liu P; Zhou Y; Chen Z; He Y; Mo M; Dai G; Xia W; Du Y; Liu Y; Chen X
Life Sci; 2019 Apr; 223():29-37. PubMed ID: 30862567
[TBL] [Abstract][Full Text] [Related]
19. Rosuvastatin preserves renal structure following unilateral ureteric obstruction in the neonatal rat.
Mazzei LJ; García IM; Altamirano L; Docherty NG; Manucha W
Am J Nephrol; 2012; 35(2):103-13. PubMed ID: 22212364
[TBL] [Abstract][Full Text] [Related]
20. Wen-pi-tang-Hab-Wu-ling-san reduces ureteral obstructive renal fibrosis by the reduction of oxidative stress, inflammation, and TGF-beta/Smad2/3 signaling.
Jung KJ; Kim J; Park YK; Yoon YR; Park KM
Food Chem Toxicol; 2010 Feb; 48(2):522-9. PubMed ID: 19913069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
